| . | Caucasian . | Hispanic . | African American . | Asian/Pacific Islander . | Native American . | P . |
|---|---|---|---|---|---|---|
| CD34+ Cells (x106/L) | ||||||
| N | 8550 | 1009 | 504 | 587 | 115 | |
| Median (range) | 33.7 (0.4-284.8) | 36.0 (3.1-151) | 44.0 (0.6-210) | 34.6 (4.4-155) | 36.8 (6.8-149) | <.001 |
| MNC (x109/L) | ||||||
| N | 8493 | 989 | 498 | 584 | 114 | |
| Median (range) | 2.8 (0.1-13.1) | 3.0 (0.2-12.1) | 3.1 (0.6-9.3) | 2.8 (0.3-7.1) | 3.1 (1.0-11.7) | <.001 |
| CD34+ Cells/MNC (x10-3) | ||||||
| N | 8492 | 989 | 498 | 584 | 114 | |
| Median (range) | 11.9 (0.1-430.0) | 12.2 (1.1-230.0) | 13.6 (0.2-150.0) | 12.5 (1.9-169.4) | 11.8 (2.8-66.8) | <.001 |
| . | Caucasian . | Hispanic . | African American . | Asian/Pacific Islander . | Native American . | P . |
|---|---|---|---|---|---|---|
| CD34+ Cells (x106/L) | ||||||
| N | 8550 | 1009 | 504 | 587 | 115 | |
| Median (range) | 33.7 (0.4-284.8) | 36.0 (3.1-151) | 44.0 (0.6-210) | 34.6 (4.4-155) | 36.8 (6.8-149) | <.001 |
| MNC (x109/L) | ||||||
| N | 8493 | 989 | 498 | 584 | 114 | |
| Median (range) | 2.8 (0.1-13.1) | 3.0 (0.2-12.1) | 3.1 (0.6-9.3) | 2.8 (0.3-7.1) | 3.1 (1.0-11.7) | <.001 |
| CD34+ Cells/MNC (x10-3) | ||||||
| N | 8492 | 989 | 498 | 584 | 114 | |
| Median (range) | 11.9 (0.1-430.0) | 12.2 (1.1-230.0) | 13.6 (0.2-150.0) | 12.5 (1.9-169.4) | 11.8 (2.8-66.8) | <.001 |